Logo Logo

Publications by Witzens-Harig, Mathias

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 5.

Journal article

Kriegsmann, Katharina; Kriegsmann, Mark; Bergwelt-Baildon, Michael von; Cremer, Martin; Witzens-Harig, Mathias (2018): NKT cells - New players in CAR cell immunotherapy? In: European Journal of Haematology, Vol. 101, No. 6: pp. 750-757

Hess, Georg; Rule, Simon; Jurczak, Wojciech; Jerkeman, Mats; Silva, Rodrigo Santucci; Rusconi, Chiara; Caballero, Dolores; Joao, Cristina; Witzens-Harig, Mathias; Bence-Bruckler, Isabelle; Cho, Seok-Goo; Zhou, Wenjiong; Goldberg, Jenna D.; Trambitas, Cristina; Enny, Christopher; Vermeulen, Jessica; Traina, Shana; Chiou, Chiun-Fang; Diels, Joris; Dreyling, Martin (2017): Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus. In: Leukemia & Lymphoma, Vol. 58, No. 12: pp. 2824-2832

Dreyling, Martin; Jurczak, Wojciech; Jerkeman, Mats; Santucci Silva, Rodrigo; Rusconi, Chiara; Trneny, Marek; Offner, Fritz; Caballero, Dolores; Joao, Cristina; Witzens-Harig, Mathias; Hess, Georg; Bence-Bruckler, Isabelle; Cho, Seok-Goo; Bothos, John; Goldberg, Jenna D.; Enny, Christopher; Traina, Shana; Balasubramanian, Sriram; Bandyopadhyay, Nibedita; Sun, Steven; Vermeulen, Jessica; Rizo, Aleksandra; Rule, Simon (2016): Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase study. In: Lancet, Vol. 387, No. 10020: pp. 770-778

Witzens-Harig, Mathias; Memmer, Marie Luise; Dreyling, Martin; Hess, Georg (2013): A phase I/II trial to evaluate the safety, feasibility and activity of salvage therapy consisting of the mTOR inhibitor Temsirolimus added to standard therapy of Rituximab and DHAP for the treatment of patients with relapsed or refractory diffuse large cell B-Cell lymphoma - the STORM trial. In: BMC Cancer 13:308 [PDF, 223kB]

Witzens-Harig, Mathias; Hensel, Manfred; Unterhalt, Michael; Herfarth, Klaus (2011): Treatment of limited stage follicular lymphoma with Rituximab immunotherapy and involved field radiotherapy in a prospective multicenter Phase II trial-MIR trial. In: BMC Cancer 11:87 [PDF, 278kB]

This list was generated on Thu Aug 22 06:19:01 2019 CEST.